Why The Relapsed/Refractory Acute Myeloid Leukemia Market Is Expected To Witness Revolutionary Developments - Financial News Media

Press/Media

Period	25 Oct 2023

Media coverage

Title	Why The Relapsed/Refractory Acute Myeloid Leukemia Market Is Expected To Witness Revolutionary Developments - Financial News Media
Media name/outlet	Chase
Country/Territory	United States
Date	25/10/23
URL	https://idc.chase.com/newspublic/story?article=0807f94fe54ee1a1&controller=newspublic&action=search&module=default
Persons	Mirna Chehade